All Stories

  1. Bloodborne pancreatic amylin, a therapeutic target for Alzheimer disease
  2. Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia
  3. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer’s Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats
  4. Cardioprotection by Controlling Hyperamylinemia in a “Humanized” Diabetic Rat Model